RFP QuestBeta
OpenStage · planning

NHS Blood and Transplant

Malaria & Arbovirus detection assays

Engineering & ArchitectureCPV 33141625
Value£1
Deadline
Published29 Feb 2024
RegionNationwide
Who to contact
Tennille Madigan
tennille.madigan@nhsbt.nhs.uk
+44 7795483583

The procurement contact named on the official notice.

Contract value in context
£1total contract value
median £123k
this tender£0£16.5m

This sits below the typical range for Medical Equipment & Pharmaceuticals contracts — a smaller, more accessible award. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity.

KEG approval of suitable assays is a requirement of the Guidelines for the Blood Transfusion Services in the United Kingdom (Red Book - https://www.transfusionguidelines.org/red-book).<br/><br/>NHSBT are looking to perform two evaluations, one on malaria detection assays and the other on arbovirus detection assays, which utilise high-throughput automated Nucleic Acid Testing (NAT) technology.

This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors.

An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.<br/><br/>These evaluations are driven by horizon scanning and testing resilience and the proposed work would be standalone evaluations not linked to any procurement exercises.

To learn more about KEG we will be holding virtual webinars in the summer of 2024.

Key requirements

What the supplier must deliver

01

The Kit Evaluation Group (KEG) assesses

The Kit Evaluation Group (KEG) assesses the suitability of molecular and serological microbiological assays to be used for the screening of blood and non-blood (e.g. stem cell, tissue) donors to ensure assays are suitable in terms of sensitivity and specificity.

02

This system needs to be integrated (extraction

This system needs to be integrated (extraction and amplification stages on the same automated equipment) and target DNA or RNA in blood samples collected from blood and non-blood donors.

03

An automated and integrated NAT system is

An automated and integrated NAT system is essential to minimise manual steps and to allow for high-throughput testing.

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at NHS Blood and Transplant, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
ocds-h6vhtk-044445
Stage
planning · Planning
Source
Find a Tender
Buyer ref
006506-2024
View the original notice on Find a Tender

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Medical Equipment & Pharmaceuticals

Assembling the market network…

NHS Blood and Transplant’s tender network

Assembling the network…

Also open now

Similar open tenders

Falls Prevention and Detection Products, Systems and Support Services

COUNTESS OF CHESTER HOSPITAL NHS FOUNDATION TRUST

Closes 29 Jul 2026Medical Equipment & Pharma
£19.5mValue